Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin Deficiency. (Q45873139)
Jump to navigation
Jump to search
scientific article published on 25 September 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin Deficiency. |
scientific article published on 25 September 2017 |
Statements
Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin Deficiency (English)
Qiushi Tang
Cynthia Greer
Ziqiong Wang
Adi Barzel
Mark A Kay
Leonard D Shultz
Dale L Greiner
Terence R Flotte
Michael A Brehm
Christian Mueller
25 September 2017
1 reference
1 reference